Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
New York, NY — ExL Events is proud to announce the release of two programs — the 8th CROWN Congress and the 8th Trial Master File Summit — taking place on January 22–24, 2019, at the Hilton Orlando Lake Buena Vista in Orlando, FL. With these two ...
read more
PROMETRIKA and Comprehend Systems have announced a partnership that will provide solutions to meet the evolving needs of biotech and pharmaceutical sponsors running clinical trials.
read more
Wednesday, August 29, 2018
Promethera Biosciences SA announced Health Canada has confirmed a cGMP compliance status for the company’s production facility in Durham, North Carolina.
read more
Promethera Biosciences and Shibuya announced a strategic collaboration to establish a high-throughput, commercial-scale and clinical-grade cell therapy and regenerative medicine manufacturing platform.
read more
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma ...
read more
Thursday, October 24, 2013
The loss of drug product during the filtration and fill process presents a major challenge to pharmaceutical and biologics manufacturers worldwide. For Cobra Biologics, a leading CMO providing aseptic manufacture for clinical and commercial supply, ...
read more
Progentec, a leader in diagnostic and digital technologies for the proactive management of autoimmune diseases, announced an 18-month collaborative research agreement with GlaxoSmithKline (GSK) to evaluate novel measurement and management tools for ...
read more
ProductLife Group (PLG), a global provider of regulatory, vigilance and quality management services for the pharmaceutical, biotech and medtech industries, announced its intention to merge with Pharma D&S Group, an Italy-based firm.
read more
ProductLife Group (PLG), a provider of regulatory, scientific, vigilance and quality services for the life sciences industries, announces the acquisition of RNI, a consultancy providing support in regulatory, medical and scientific affairs for ...
read more
Thursday, October 31, 2024
ProductLife Group (PLG), a provider of regulatory, scientific, compliance, and digital transformation consulting services for the life sciences industry, announced the acquisition of Callisto, a UK-based consultancy specializing in Regulatory Affairs...
read more
Thursday, November 18, 2021
ProcureNet, a global supplier of pharmaceutical materials and vaccines consumables, signed an MOU aiming to help vaccinate 2 billion people next year through its vaccination supply network which will include Anhui Tiankang Medical, a hi-tech medical ...
read more
Processa has entered into a licensing agreement with Yuhan, a South Korean based company, to license in YH12852.
read more
Processa has signed an agreement with Aposense to license in the patent rights to develop and commercialize their next generation irinotecan cancer drug, ATT-11T.
read more
Thursday, January 13, 2022
Procaps Group announced the closing of an asset purchase agreement to acquire an 86,000 sq. ft. pharmaceutical production facility located in Florida with production capacity of approximately 1.8 billion capsules per year.
read more
ProBioGen AG and Pionyr Immunotherapeutics have announced a second service and license agreement to develop novel antibody therapeutics.
read more